HCM burden
HCM is more prevalent than you may think and can lead to an increased risk of comorbidities and mortality as well as negatively impact patients' daily lives.1,2
Path to diagnosis
HCM is often challenging to diagnose due to its varied presentation and overlapping symptoms with other diseases.1,2
Managing HCM
Regular monitoring and evaluation of patients is important, as current treatments are limited primarily to symptom management.1,2
References
- Ommen SR, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;142(25):e558-e631.
- Naidu, Srihari S, editor. Hypertrophic Cardiomyopathy. Second ed., Springer International Publishing, 2019.
- Gersh BJ, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2011;142(6):e153-203.
- Maron MS, et al. Occurrence of clinically diagnosed hypertrophic cardiomyopathy in the United States. Am J Cardiol. 2016;117(10):1651-4.